418 related articles for article (PubMed ID: 17136470)
21. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
[TBL] [Abstract][Full Text] [Related]
22. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
Badiee S; Franc BL; Webb EM; Chu B; Hawkins RA; Coakley F; Singer L
AJR Am J Roentgenol; 2008 Nov; 191(5):1436-9. PubMed ID: 18941082
[TBL] [Abstract][Full Text] [Related]
23. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
[TBL] [Abstract][Full Text] [Related]
24. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.
Prytz H; Keiding S; Björnsson E; Broomé U; Almer S; Castedal M; Munk OL;
Hepatology; 2006 Dec; 44(6):1572-80. PubMed ID: 17133469
[TBL] [Abstract][Full Text] [Related]
25. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
Adie S; Yip C; Chu F; Morris DL
ANZ J Surg; 2009 May; 79(5):358-61. PubMed ID: 19566517
[TBL] [Abstract][Full Text] [Related]
26. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC
Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072
[TBL] [Abstract][Full Text] [Related]
27. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ
J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565
[TBL] [Abstract][Full Text] [Related]
28. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
29. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
García Vicente AM; Domínguez Ferreras E; Sánchez Pérez V; Poblete García VM; Villa Guzmán JC; Jiménez Aragón F; Pineda Pineda MD; Molino Trinidad C; Soriano Castrejón Á
Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
[TBL] [Abstract][Full Text] [Related]
30. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
Fong Y; Saldinger PF; Akhurst T; Macapinlac H; Yeung H; Finn RD; Cohen A; Kemeny N; Blumgart LH; Larson SM
Am J Surg; 1999 Oct; 178(4):282-7. PubMed ID: 10587184
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.
Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA
AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891
[TBL] [Abstract][Full Text] [Related]
32. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation).
Elias D; Sideris L; Pocard M; de Baere T; Dromain C; Lassau N; Lasser P
Ann Surg Oncol; 2005 Apr; 12(4):298-302. PubMed ID: 15827682
[TBL] [Abstract][Full Text] [Related]
33. The role of FDG-PET in the selection of patients with colorectal liver metastases.
Wiering B; Krabbe PF; Dekker HM; Oyen WJ; Ruers TJ
Ann Surg Oncol; 2007 Feb; 14(2):771-9. PubMed ID: 17086488
[TBL] [Abstract][Full Text] [Related]
34. Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.
Revheim ME; Haugvik SP; Johnsrud K; Mathisen Ø; Fjeld JG; Skretting A
Acta Radiol; 2015 Apr; 56(4):397-403. PubMed ID: 24682406
[TBL] [Abstract][Full Text] [Related]
35. A comparison of diagnostic imaging modalities for colorectal liver metastases.
Bonanni L; de'Liguori Carino N; Deshpande R; Ammori BJ; Sherlock DJ; Valle JW; Tam E; O'Reilly DA
Eur J Surg Oncol; 2014 May; 40(5):545-550. PubMed ID: 24491289
[TBL] [Abstract][Full Text] [Related]
36. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
[TBL] [Abstract][Full Text] [Related]
37. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Ruers TJ; Wiering B; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Krabbe PF; Oyen WJ
J Nucl Med; 2009 Jul; 50(7):1036-41. PubMed ID: 19525451
[TBL] [Abstract][Full Text] [Related]
38. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide.
Vidiri A; Carpanese L; Annibale MD; Caterino M; Cosimelli M; Zeuli M; David V; Crecco M
J Exp Clin Cancer Res; 2004 Mar; 23(1):53-60. PubMed ID: 15149151
[TBL] [Abstract][Full Text] [Related]
40. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
van Laarhoven HW; de Geus-Oei LF; Wiering B; Lok J; Rijpkema M; Kaanders JH; Krabbe PF; Ruers T; Punt CJ; van der Kogel AJ; Oyen WJ; Heerschap A
Radiology; 2005 Oct; 237(1):181-8. PubMed ID: 16183932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]